REG - Zotefoams PLC - 2024 Annual Report & Notice of 2025 AGM

ZotefoamsAnnouncement

22/04/2025 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250422:nRSV5485Fa&default-theme=true

RNS Number : 5485F  Zotefoams PLC  22 April 2025

Zotefoams plc

(the 'Company' or the 'Group')

 

2024 Annual Report and Notice of the 2025 Annual General Meeting

 

22 April 2025 - The Company has published its 2024 Annual Report and the
Notice of the 2025 Annual General Meeting to be held at 675 Mitcham Road,
Croydon CR9 3AL on 22 May 2025 at 10.00 a.m. on:

https://www.zotefoams.com/investors/financial-updates/
(https://www.zotefoams.com/investors/financial-updates/)

 

In compliance with Listing Rule 9.6.1, the following documents will be
submitted to the National Storage Mechanism and will shortly be available for
inspection at:

https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism)

 

 1.  Annual Report for the year ended 31 December 2024, prepared using the single
     electronic reporting format specified in the TD ESEF Regulation and
     incorporating the Notice of the 2025 Annual General Meeting; and
 2.  Form of Proxy for the 2025 Annual General Meeting.

 

A condensed set of the financial statements, the Chair's introduction, the
Group CEO's review and the Group CFO's review, in respect of the 2024 Annual
Report, were included in the unaudited preliminary results announcement issued
on 18 March 2025, which may be found at:

https://www.zotefoams.com/investors/regulatory-news/
(https://www.zotefoams.com/investors/regulatory-news/)

 

This announcement contains, in Annex A, additional information for the
purposes of compliance with the Disclosure, Guidance and Transparency Rules,
including the statement of Directors' responsibilities in respect of the
financial statements, a description relating to principal risks and
uncertainties, and details of related party transactions. This information is
extracted from the 2024 Annual Report. This announcement is not a substitute
for reading the full Annual Report. Page and note references in the text below
refer to page numbers and notes in the 2024 Annual Report.

 

 

Enquiries:

 

Lydia Harratt

Group Company Secretary

Zotefoams plc

020 8664 1600

 

About Zotefoams plc

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in supercritical fluid foam
technology, delivering optimal material solutions for the benefit of society.
Utilising a variety of unique manufacturing processes, including
environmentally friendly nitrogen expansion for lightweight AZOTE(®) and
ZOTEK(®) high-performance foams, Zotefoams sells to diverse markets worldwide
across three market verticals, Consumer & Lifestyle, Transport & Smart
Technologies, and Construction & Other Industrial. Zotefoams uses its own
materials to manufacture T-FIT(®) advanced insulation for demanding
industrial markets.

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites
in Kentucky, USA and Brzeg, Poland (foam manufacture), and foam products
conversion in Oklahoma, USA and Jiangsu Province, China (T-FIT) .

www.zotefoams.com (http://www.zotefoams.com)

AZOTE(®), ZOTEK(®) and T-FIT(®) are registered trademarks of Zotefoams plc.

Annex A

 

Statement of Directors' responsibilities in respect of the financial
statements

The Directors consider the Annual Report, taken as a whole, to be fair,
balanced and understandable.

The Directors are responsible for preparing the Annual Report and the
financial statements in accordance with applicable law and regulation.

Company law requires the Directors to prepare financial statements for each
financial year. Under that law, the Directors have prepared the Group and
Company financial statements in accordance with UK-adopted international
accounting standards. Under company law, the Directors must not approve the
financial statements unless they are satisfied that they give a true and fair
view of the state of affairs of the Group and Company and of the profit or
loss of the Group and Company for that period. In preparing the financial
statements, the Directors are required to:

 ·   Select suitable accounting policies and then apply them consistently
 ·   State whether applicable UK-adopted international accounting standards have
     been followed subject to any material departures disclosed and explained in
     the financial statements
 ·   Make judgements and accounting estimates that are reasonable and prudent and
 ·   Prepare the financial statements on the going concern basis unless it is
     inappropriate to presume that the Group and Company will continue in business.

The Directors are also responsible for safeguarding the assets of the Group
and Company and hence for taking reasonable steps for the prevention and
detection of fraud and other irregularities.

The Directors are responsible for keeping adequate accounting records that are
sufficient to show and explain the Group's and Company's transactions and
disclose with reasonable accuracy at any time the financial position of the
Group and Company and enable them to ensure that the financial statements and
the Directors' Remuneration report comply with the Companies Act 2006.

The Directors are responsible for the maintenance and integrity of the
Company's website. Legislation in the United Kingdom governing the preparation
and dissemination of financial statements may differ from legislation in other
jurisdictions.

The Directors consider that the Annual Report, taken as a whole, is fair,
balanced and understandable and provides the information necessary for
shareholders to assess the position and performance, business model and
strategy of the Group and Company.

Each of the Directors, whose names and functions are listed on pages 72 and 73
of the Annual Report, confirm that, to the best of their knowledge:

 ·   The Consolidated and Company financial statements, which have been prepared in
     accordance with UK-adopted international accounting standards, give a true and
     fair view of the assets, liabilities, financial position and profit of the
     Group and Company and
 ·   The Group CEO's review includes a fair review of the development and
     performance of the business and the position of the Group and Company. A
     description of the principal risks and uncertainties faced by the Group and
     the Company is provided on pages 41 to 50.

 

Principal risks and uncertainties

The Group is exposed to a wide range of risks in addition to those listed, and
these are managed through the risk management framework shown on page 40. This
framework enables us to monitor for any increase in likelihood or impact and
ensure that we have the appropriate mitigations in place. The details of our
principal risks and uncertainties and the key mitigating activities can be
found on pages 41 to 50. We are disclosing those risks and uncertainties that
we believe have the greatest impact in achieving our strategic objectives.

Zotefoams' risk profile will evolve as the business grows at its targeted
pace, although we expect these principal risks and uncertainties to remain
broadly consistent.

 

Related party transactions

 

Directors

The Directors of the Company as at 31 December 2024 and their immediate
relatives control approximately 0.9% (2023: 1.3%) of the voting shares of the
Company. Details of Directors' pay and remuneration are given in the
Directors' Remuneration report on pages 84 to 97. Executive Directors are
considered to be the only key management personnel. Details of compensation
paid to key management personnel are included in note 6.

 

Subsidiaries and joint venture

Details of the joint venture and subsidiaries of the Company are set out in
notes 10 and 14. These companies are considered to be related parties.

 

The following material transactions were carried out with related parties:

                                                                   2024     2023

£'000
£'000
 Sale of goods: subsidiaries of the Company                        3,954    4,434
 Sale of services: subsidiaries of the Company                     3,528    2,598
 Loans granted (net of repayments) to subsidiaries of the Company  2,089    (708)
 Interest income: subsidiaries of the Company                      1,372    1,302
 Sale of goods: joint venture of the Company                       3,514    2,944
 Sale of service: joint venture of the Company                     558      368
 Total                                                             15,015   10,938

 

Balances between the Company and its active subsidiaries and joint venture are
as follows:

 

                                                        Receivable from/(payable to)      Investment in
                                                        2024             2023             2024     2023

£'000
£'000
£'000
£'000
 Zotefoams Inc                                          20,249           12,669           -        -
 Azote Asia Limited                                     1,257            1,000            -        -
 MuCell Extrusion LLC                                   -                7,904            -        -
 Zotefoams International Limited                        12,983           15,487           30,822   30,822
 Zotefoams Operations Limited                           (18)             -                -        -
 Zotefoams T-FIT Material Technology (Kunshan) Limited  796              2,014            -        -
 Zotefoams Poland Sp. z o.o.                            1,828            1,190            -        -
 Zotefoams France SAS                                   (107)            (73)             -        -

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ACSPKOBPFBKDOQD